ResMed Inc.

NYSE

Market Cap.

35.3B

Avg. Volume

863.11K

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

AI Generated Qualitative Analysis

AI

Your time is precious, so save it. Use AI to get the most important information from the business.

Learn about ResMed Inc.

ResMed Inc. News

ResMed Inc. Quantitative Score

Overall Score

Business

Growth

Unlock

Business

Quality

Unlock

Stock

Value

Unlock

Price

Move

Price

Momentum

Unlock

Price

Stability

Unlock
Website screenshot
HealthcareMedical - Instruments & Supplies
resmed.com

About ResMed Inc.

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

ResMed Inc. Earnings & Revenue

ResMed Inc. Financials

Table Compare

Compare RMD metrics with:

   

Earnings & Growth

RMD

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

RMD

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

RMD

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

RMD

None

Debt/Assets Ratio

--

--

Assets/Liabilities Ratio

--

--

 

ResMed Inc. Income

ResMed Inc. Balance Sheet

ResMed Inc. Cash Flow

ResMed Inc. Financials Over Time

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityBuy
Return on AssetsStrong Buy
Debt/Equity RatioSell
Price/Earnings RatioStrong Sell
Price/Book RatioStrong Sell

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

ResMed Inc. Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

2.0700

Payment DateDividendFrequency
2025-03-200.53Quarterly
2024-12-120.53Quarterly
2024-09-190.53Quarterly
2024-06-130.48Quarterly
2024-03-140.48Quarterly

ResMed Inc. Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Historical Market Cap

Shares Outstanding

ResMed Inc. Executives

NameRole
Mr. Michael J. Farrell BE, MBA, SMChief Executive Officer & Chairman
Mr. Kaushik GhoshalChief Commercial Officer - SaaS
Mr. Justin LeongChief Product Officer
Mr. Brett A. SandercockChief Financial Officer
Mr. Michael J. RiderChief Legal Officer & Secretary
NameRoleGenderDate of BirthPay
Mr. Michael J. Farrell BE, MBA, SMChief Executive Officer & ChairmanMale19722.92M
Mr. Kaushik GhoshalChief Commercial Officer - SaaSMale19681.23M
Mr. Justin LeongChief Product OfficerMale19771.2M
Mr. Brett A. SandercockChief Financial OfficerMale1967933.66K
Mr. Michael J. RiderChief Legal Officer & SecretaryMale1958854.32K

ResMed Inc. Insider Trades

Date3 Feb
NameRider Michael J
RoleGlobal General Counsel
TransactionDisposed
TypeS-Sale
Shares64
Date8 Jan
NameSandercock Brett
RoleChief Financial Officer
TransactionDisposed
TypeS-Sale
Shares1000
Date2 Jan
NameFARRELL PETER C
RoleDirector
TransactionDisposed
TypeS-Sale
Shares2000
Date2 Jan
NameRider Michael J
RoleGlobal General Counsel
TransactionDisposed
TypeS-Sale
Shares75
Date9 Dec
NameSandercock Brett
RoleChief Financial Officer
TransactionDisposed
TypeS-Sale
Shares1000
DateNameRoleTransactionTypeShares
3 FebRider Michael JGlobal General CounselDisposedS-Sale64
8 JanSandercock BrettChief Financial OfficerDisposedS-Sale1000
2 JanFARRELL PETER CDirectorDisposedS-Sale2000
2 JanRider Michael JGlobal General CounselDisposedS-Sale75
9 DecSandercock BrettChief Financial OfficerDisposedS-Sale1000

Discover More

Streamlined Academy

ResMed Inc.

NYSE

Market Cap.

35.3B

Avg. Volume

863.11K

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

ResMed Inc. News

ResMed Inc. Quantitative Score

Overall Score

Business

Growth

Unlock

Business

Quality

Unlock

Stock

Value

Unlock

Price

Move

Price

Momentum

Unlock

Price

Stability

Unlock

ResMed Inc. Earnings & Revenue

ResMed Inc. Income

ResMed Inc. Balance Sheet

ResMed Inc. Cash Flow

ResMed Inc. Financials Over Time

ResMed Inc. Executives

NameRole
Mr. Michael J. Farrell BE, MBA, SMChief Executive Officer & Chairman
Mr. Kaushik GhoshalChief Commercial Officer - SaaS
Mr. Justin LeongChief Product Officer
Mr. Brett A. SandercockChief Financial Officer
Mr. Michael J. RiderChief Legal Officer & Secretary
NameRoleGenderDate of BirthPay
Mr. Michael J. Farrell BE, MBA, SMChief Executive Officer & ChairmanMale19722.92M
Mr. Kaushik GhoshalChief Commercial Officer - SaaSMale19681.23M
Mr. Justin LeongChief Product OfficerMale19771.2M
Mr. Brett A. SandercockChief Financial OfficerMale1967933.66K
Mr. Michael J. RiderChief Legal Officer & SecretaryMale1958854.32K

ResMed Inc. Insider Trades

Date3 Feb
NameRider Michael J
RoleGlobal General Counsel
TransactionDisposed
TypeS-Sale
Shares64
Date8 Jan
NameSandercock Brett
RoleChief Financial Officer
TransactionDisposed
TypeS-Sale
Shares1000
Date2 Jan
NameFARRELL PETER C
RoleDirector
TransactionDisposed
TypeS-Sale
Shares2000
Date2 Jan
NameRider Michael J
RoleGlobal General Counsel
TransactionDisposed
TypeS-Sale
Shares75
Date9 Dec
NameSandercock Brett
RoleChief Financial Officer
TransactionDisposed
TypeS-Sale
Shares1000
DateNameRoleTransactionTypeShares
3 FebRider Michael JGlobal General CounselDisposedS-Sale64
8 JanSandercock BrettChief Financial OfficerDisposedS-Sale1000
2 JanFARRELL PETER CDirectorDisposedS-Sale2000
2 JanRider Michael JGlobal General CounselDisposedS-Sale75
9 DecSandercock BrettChief Financial OfficerDisposedS-Sale1000

Streamlined Academy

Website screenshot
HealthcareMedical - Instruments & Supplies
resmed.com

About ResMed Inc.

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

AI Generated Qualitative Analysis

AI

Your time is precious, so save it. Use AI to get the most important information from the business.

Learn about ResMed Inc.

ResMed Inc. Financials

Table Compare

Compare RMD metrics with:

   

Earnings & Growth

RMD

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

RMD

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

RMD

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

RMD

None

Debt/Assets Ratio

--

--

Assets/Liabilities Ratio

--

--

 

ResMed Inc. Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

2.0700

Payment DateDividendFrequency
2025-03-200.53Quarterly
2024-12-120.53Quarterly
2024-09-190.53Quarterly
2024-06-130.48Quarterly
2024-03-140.48Quarterly

ResMed Inc. Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityBuy
Return on AssetsStrong Buy
Debt/Equity RatioSell
Price/Earnings RatioStrong Sell
Price/Book RatioStrong Sell

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Discover More

A Practical Guide: How To Analyze Any Stock (With Examples)